Thrombolex, Inc. — Form D/A

Thrombolex, Inc. of Kingston, NJ, a company, filed a Form D amendment with the SEC on 2020-02-03. $9.8M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Marvin WoodallDirectorRaleigh, NC
John G CerminaroExecutive OfficerNew Britain, PA
Marvin WoodallExecutive OfficerRaleigh, NC
Michael J CerminaroPromoterKingston, NJ
Marvin WoodallPromoterRaleigh, NC
John A CerminaroExecutive OfficerKingston, NJ
Marvin J WoodallDirectorKingston, NJ
Marvin J WoodallExecutive OfficerKingston, NJ
Kelly A ElliottDirectorKingston, NJ
Todd A RichmondDirectorKingston, NJ
Michael J CerminaroDirectorKingston, NJ
Michael J CerminaroExecutive OfficerKingston, NJ
Tony J LitwillerExecutive OfficerKingston, NJ
Paul A StewartDirectorMilwaukee, WI
Brian G FirthDirectorKingston, NJ
Brian G FirthExecutive OfficerKingston, NJ
David A. BonitaDirectorKingston, NJ
Keegan A. HarperDirectorKingston, NJ
Paul A. StewartDirectorKingston, NJ
Sam A. LiangDirectorKingston, NJ
Marvin J. WoodallDirectorKingston, NJ
Marvin J. WoodallExecutive OfficerKingston, NJ
John J. CerminaroExecutive OfficerKingston, NJ
Clay A. DeMarcusDirectorKingston, NJ
Michael J. CerminaroDirectorKingston, NJ

Other filings by this issuer (7)

FiledFormOfferingSold
2026-03-12D$51.1M$32.8M
2024-06-21D$5.0M$1.2M
2024-05-28D$4.8M$4.8M
2022-08-30D$2.0M$2.0M
2021-11-29D$5.0M$5.0M
2018-04-17D/A$3.5M
2017-04-17D$1.5M$400K

More